Rocket Pharmaceuticals, Inc. (RCKT)
3.10
+0.13
(+4.38%)
USD |
NASDAQ |
May 21, 16:00
3.10
0.00 (0.00%)
After-Hours: 19:59
Rocket Pharmaceuticals EPS Diluted (Quarterly) : -0.4244 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AnaptysBio, Inc. | -1.843 |
| Arcus Biosciences, Inc. | -1.021 |
| Replimune Group, Inc. | -0.7694 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.59M |
| Total Expenses (Quarterly) | 47.59M |
| Enterprise Value | 204.69M |
| Earnings Yield | -60.54% |
| Normalized Earnings Yield | -59.82 |